UH Harrington Heart & Vascular Institute News to Know

Year-End Message: A Time to Reflect and be Proud

We hope you’ll agree 2017 was a year filled with excitement. Together we overcame many challenges and, once again, achieved unprecedented success. We would like to thank each of you for the trust, relentless commitment and teamwork that you demonstrated every day to advance the UH Harrington Heart & Vascular Institute closer to our vision:

“Be the most trusted, integrated academic heart and vascular institute that anchors a healthy community and defines the future of medicine.”

The strategic plan crafted by many of you in 2016 continues to guide our decisions. In reviewing highlights of our 2017 accomplishments, we have made much progress.

Read Dr. Costa and Eric Hess’ full message here. <https://uhcommunity.uhhospitals.org/HarringtonHeartVascularInstitute/Pages/End-of-Year-Message-from-Dr--Marco-Costa-and-Eric-Hess.aspx> (internal)

 

UH Harrington Heart & Vascular Institute to Create First-of-its-Kind Advanced Interventional Cardiovascular Center at UH Cleveland Medical Center

The UH Harrington HVI Advanced Interventional Cardiovascular Center will transform patient care and showcase UH as the home of the most innovative treatment options available today.

Multi-million dollar strategic partnerships with Medtronic and Siemens will change the way cardiovascular care is delivered at UH Cleveland Medical Center and in the world. The first-of-its-kind Advanced Interventional Cardiovascular Center will co-locate a robotically operated cardiac catheterization lab and operating room with cardiac magnetic resonance imaging (MRI) and cardiac computer tomography (CT) scanners. This innovative care delivery system will be unlike any other, and will offer patients the most advanced, efficient and cost-effective cardiovascular diagnosis and treatment services available.

Read more about the UH Harrington HVI Advanced Interventional Cardiovascular Center here. <https://uhcommunity.uhhospitals.org/News/Pages/First-of-its-Kind-Advanced-Interventional-Cardiovascular-Center-at-UH-Cleveland-Medical-Center.aspx> (internal)

 

UH Physician Scientist Co-Authors New Hypertension Guidelines

The American Heart Association and the American College of Cardiology have published new guidelines for the detection, prevention, management and treatment of high blood pressure. Jackson T. Wright, Jr., MD, PhD, Program Director of the William T. Dahms Clinical Research Unit and Director, Clinical Hypertension Program, both at UH Cleveland Medical Center, co-authored the study.

High blood pressure is now defined as readings of 130 mm Hg and higher for systolic and readings of 80 and higher for diastolic. Additionally, the category of prehypertension has been eliminated.

Read the AHA press release here. <http://newsroom.heart.org/news/high-blood-pressure-redefined-for-first-time-in-14-years-130-is-the-new-high?utm_campaign=sciencenews17-18&utm_source=science-news&utm_medium=phd-link&utm_content=phd11-13-17_htn-gl>

Read an interview with Dr. Wright here. <https://uhcommunity.uhhospitals.org/News/Pages/Who-Is-Considered-to-Have-High-Blood-Pressure.aspx> (internal)

 

Alabama Man Suffers “Widow-Maker” Heart Attack in Ohio, Saved by UH

On the morning of Oct. 2, 2017, Jeff Colvin awoke with pain in his chest. The long-haul driver from Alabama had spent the night in his 18-wheel semi tractor-trailer at an Austinburg, Ohio truck stop before heading out for another full day on the road. Initially, the 56-year old attributed the pain to indigestion, but when he began sweating and feeling nauseous, he knew it was serious. So, he called 9-1-1.

First responders transported Jeff to UH Geneva Medical Center where physicians determined he was having a heart attack. From there, Jeff was flown to UH Cleveland Medical Center where UH Harrington HVI Interventional Cardiologist Ankur Kalra, MD, was waiting for him.

Read Jeff’s story on UHhospitals.org here. <http://www.uhhospitals.org/services/heart-and-vascular/institute/patient-resources/patient-stories/jeffs-story>

 

UH Harrington HVI Services Expanding at UH St. John Medical Center and UH Westlake Health Center

In order to meet the growing need for high-quality cardiovascular care on the west side, UH Harrington Heart & Vascular Institute has expanded access at UH St. John Medical Center and UH Westlake Health Center. Physicians specializing in general cardiology, interventional cardiology, vascular surgery, advanced heart failure and electrophysiology are now available at the UH Harrington Heart & Vascular Institute locations on Center Ridge Road, Health Campus Drive and Clague Road, and Friday office hours were added at UH Westlake. In addition to provider appointments at these locations, patients can now access our Coumadin Clinic along with Echo, EKG, stress and vascular testing.

View a provider flyer, including contact information here.  <https://uhcommunity.uhhospitals.org/HarringtonHeartVascularInstitute/Lists/Harrington%20Heart%20%20Vascular%20Institute%20Site%20Announce/Attachments/2/HVI%20729667%20Expanded%20Access%20Flyer_r4_FINAL.pdf> (internal)

 

UH Celebrates 70th Anniversary of World’s First Successful Cardiac Defibrillation

This month marks an important milestone in University Hospitals’ history – the 70th anniversary of the world’s first successful human cardiac defibrillation. The landmark event, which took place at UH Cleveland Medical Center, defined the future of cardiovascular medicine and ushered in a new era of advanced cardiac life support.

Read more about this historically significant event here. <https://uhcommunity.uhhospitals.org/News/Pages/UH-Celebrates-70th-Anniversary-of-World’s-First-Successful-Cardiac-Defibrillation.aspx>

 

11th Annual Cardiovascular Update a Success

The 11th annual Cardiovascular Update was held on Wednesday, Oct. 4 at Landerhaven. More than 350 attendees were present at the event, which covered topics including: Restoring Structural Heart Function, Making a Difference for Patients with PAD and Managing Heart Failure and Preventing Sudden Cardiac Death. For those who missed the event, recordings of the evening’s presentations will be available online soon.

 

Annual “Heart Heroes” Event Brings Survivors and Caregivers Together

In partnership with the UH EMS Institute, UH Harrington Heart & Vascular Institute hosted the annual “Heart Heroes” dinner on Nov. 1 at the Embassy Suites in Beachwood. Approximately 300 guests attended to hear patients who have experienced heart-related events share their stories of success, while enjoying the opportunity to mingle with the first responders, physicians and other caregivers who contributed to  their positive outcomes.

Save the date for next year’s event – Oct. 24, 2018.

 

Save The Date: 9th Annual Cardiovascular Nursing Symposium, Continuing Nursing Education

March 6, 2018

Plan to join UH for the Cardiovascular Nursing Symposium, Continuing Nursing Education <https://uhcommunity.uhhospitals.org/HarringtonHeartVascularInstitute/Documents/HVI_Nursing%20Symposium%202018%20Flyer.pdf> (internal), on March 6, 2018.

The agenda <https://uhcommunity.uhhospitals.org/HarringtonHeartVascularInstitute/Documents/HVI_Nursing%20Symposium%202018%20Flyer.pdf> (internal) includes:

Michael Brown, DO: May-Thurner Syndrome

Mehdi Shishebor, DO, MPH, PhD: Update on Peripheral Arterial Disease Dina Sparano, MD: Update on Cardiac Implantable Devices Monique Robinson, MD, PhD: Women and Heart Failure Anjan Gupta, MD:  Recent Advances in Management of Acute Myocardial Infarction Melissa Noel, RN and Marc Streem, RN: STEMI Case Study

 

Continuing Nursing Education

5.5 contact hours available with 80 percent attendance and completed evaluation.

University Hospitals is an approved provider of continuing nursing education by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91) (OH-003, 05/01/2017)

Register by calling 1-800-355-9992 with the information below and your credit card number.

Notice of cancellation must be received in writing by Tuesday, Feb. 27, 2018.

Register in advance for your chance to win!

Register by Friday, March 2, 2018 to be entered into a drawing for one of two raffle baskets. The drawing will take place at the end of the symposium. The winner must be present to claim prize or an alternate name will be drawn.

Tuition

UH employee - $50

Non-UH employee - $60

Student or non-clinical - $25

 

CLINICAL TRIAL HIGHLIGHTS AND INFORMATION

ASPIRE Trial

Sanjay Rajagopalan, MD, FACC, FAHA, Chief, Division of Cardiovascular Medicine at UH Cleveland Medical Center, is the Principal Investigator of the ASPIRE trial. With a $2 million+ grant from the National Institutes of Health, Dr. Rajagopalan will examine the effects of wearing masks in heavily polluted cities.

Along with India, China dwarfs the rest of the world in terms of the levels of air pollution and the complications that arise from it. Exposure to ambient particles promote many illnesses, but cardiovascular diseases account for roughly 57 percent of these deaths, with southeast Asia contributing nearly 60 percent of the total.

The ASPIRE trial will take place in Beijing and other Chinese cities.

Click here to read the CRWU press release about the ASPIRE trial. <http://casemed.case.edu/cwrumed360/news-releases/release.cfm?news_id=854>

 

Engage with us!

Questions or comments?

Contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Recent News

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10